Field of the Invention
The present invention is directed to an intra-pericardial surgically introduced positioning structure that is disposed and structured to repetitively assume an expanded orientation and a contracted orientation. As such, a repetitively and temporarily “lifting” or “shaping” force is exerted on the exterior of the myocardium in synchronization with the heartbeat thereby positioning the leaflets of the mitral valve to close to a sufficient degree to eliminate or restrict mitral regurgitation.
Description of the Related Art
As clearly disclosed in the prior art schematic representation of
As indicated, the mitral valve is disposed in flow regulating communication between the left atrium and the left ventricle. The structural and/or operative components of the mitral valve comprises two valve leaflets, the mitral valve annulus, which forms a ring that supports the valve leaflets; papillary muscles, which tether the valve leaflets to the left ventricle wall, thereby preventing them from prolapsing back into the left atrium. Chordae tendineae serve to connect the mitral valve leaflets to the papillary muscles thereby further preventing the leaflets from prolapsing back into the left atrium. A dysfunction of any of the described mitral valve apparatus can cause “mitral regurgitation”. Mitral regurgitation is a disorder of the heart in which the leaflets of the mitral valve do not close properly when the heart pumps out blood. This abnormal leaking of blood from the left ventricle, through the mitral valve and, into the left atrium when the left ventricle contracts, results in the “regurgitation” of blood back into the left atrium. It is generally recognized in the medical profession that mitral regurgitation is the second most common form of valvular heart disease.
As generally set forth above, when properly functioning, the anterior and posterior valve leaflets of the mitral valve overlap during contraction of the left ventricle and prevent blood from flowing back into the left atrium. This overlap of the two leaflets leaning upon each other is called the “coaptation” and absorbs most of the strain on the mitral apparatus during the ventricular contraction. However, when the mitral valve malfunctions, due to various cardiac diseases, the leaflets are no longer coapting resulting in the mitral valve remaining partially open during ventricular contraction. In turn this allows the aforementioned “regurgitation” of the blood back into the left atrium, as generally set forth above. When the mitral valve does not close hermetically during the ventricular contraction, the aforementioned back flow of blood to the atrium and the pulmonary vasculature, results in a deleterious condition. More specifically, this condition increases the work load to the heart and may lead to heart failure.
The mitral valve is intended to open fully so as to provide no resistance to the blood stream progressing from the left atrium (LA) into the left ventricle (LV) during diastoly (the ventricular relaxation phase) and to close fully during the systoly (the ventricular ejection phase) so as to prevent the blood from flowing back into the atrium and into the pulmonary venous circulation. The role of the mitral valve is therefore to ensure antegrade progression of the blood through the left cardiac chambers. It works in synchrony with the three other heart valves that are ensuring the same function between the right atrium (RA) i.e. the pulmonic valve and downstream to the mitral valve, between the left ventricle and the aorta i.e. the aortic valve at the junction.
From a mechanical standpoint the mitral valve has to face high gradients of pressure during the ventricular contraction to hold up against a pressure head of about 100 mm of mercury (Hg) or more, which is substantially the peak pressure in the LV being usually superior or equal to 110 mmHg and the one in the atrium around 8 mmHg. This strain is absorbed mostly by the coaptation of the two mitral leaflets when closed, leaning on each other with a contact height around 10 mm over the entire length of the mitral coaptation line. The coaptation of the leaflets depends on the adequate anatomy (integrity of their structures) and adequate function of 5 components, which are 1. the mitral annulus, 2. the anterior and posterior leaflets, 3. the mitral chordae, 4. the papillary muscles (PPM) and 5. the ventricular walls themselves. Any congenital malformation or acquired lesion of one or more of these components can lead to a mitral insufficiency—also known as mitral regurgitation (MR) or, as emphasized herein, a failure of the mitral valve to hermetically close during the ventricular contraction and the leaking of a variable amount of blood back into the LA.
This situation is correlated with a poor outcome for the patient, since it increases the workload to the heart, as well as it increases the left atrial and ventricular chambers volumes. Furthermore, the existence of severe mitral regurgitation and ventricular dilation generate a vicious cycle in which MR begets more MR. Indeed, when the ventricle increases in size the distance between the papillary muscles increases, tethering the mitral chordae and impeding their full motion up to the plane of the annulus. This pathophysiological continuum leads to heart failure, pulmonary hypertension, atrial fibrillation and ultimately death.
Known treatment for MR comprises the administration of pharmacological drugs and the fixing the regurgitation by either, a surgical repair (the vast majority of the cases >98%) including a surgical repair or replacement of the valve or in some selected cases, using an emerging percutaneous technology that is still under evaluation (the Mitraclip®). Although there is a considerable trend to fix the MR as early as possible in its natural course, the indication and timing of the intervention rely also on the etiology of the condition, as well as on the functional anatomy and structural damage to the valve and the ventricle.
One particular case of mitral regurgitation targeted by the present invention is called ischemic mitral regurgitation (IMR). Ischemia to the heart relates to an insufficient blood supply to the myocardium because of narrowed (stenosed) coronary arteries. This condition is extremely prevalent and the number one killer in the USA. The natural history of coronary artery disease (stenosis) is to evolve towards acute vessel occlusion leading to acute myocardial infarction (myocardial necrosis i.e. cellular death secondary to cellular asphyxia in the territory irrigated by the occluded artery). The onset of mitral ischemia is a very bad prognostic factor in the acute phase of myocardial infarction.
Repairing ischemic mitral insufficiency poses particular problems and challenges that have been approached in different ways. However, many of such approaches have been disappointing on the very mid-term, with most studies reporting ≧40% of failure rate only two years after the surgery. Most of the proposed solutions are targeted towards the annulus and the leaflets although the mitral valve apparatus is anatomically normal and the functional problem is of ventricular origin. Indeed, the scar tissue replacing the death of the myocardium during the body repair process is immobile and remains distended in systoly. Therefore, by tethering as above-mentioned, the mobility of the entire mitral apparatus attached to it is impaired resulting in the PPM, the chordae and the leaflets being pulled “down” or away from the plane of the mitral annulus. This impeaches the leaflet (usually the posterior leaflet) to reach the point where it should coapt with its anterior counterpart. More technically, this mechanism corresponds to a type IIIb according to Carpentier's classification. It is an extremely frequent phenomenon.
Similarly other, “non-ischemic” etiologies leading to mitral regurgitation, such as for example idiopathic cardiomyopathy, could benefit from the implementation and practice of one or more to the embodiments of the present invention, as described in detail herein. An alternative solution allowing an easier, safer and possibly more durable reduction or disappearance of the mitral regurgitation has been sought, based on the premise that the IMR is a “ventricular disease” thereby suggesting a ventricular solution rather than concentrating on an approach to a normal annulus or normal leaflet.
Accordingly, there is a need in the medical arts for appropriate instrumentation, method and/or system of overcoming heart valve malfunctions, specifically including mitral regurgitation, as described above.
The present invention is directed to an intra-pericardial surgically introduced positioning structure that is disposed between the inner surface of the pericardium and the outer surface of the myocardium. Moreover, the positioning structure is operative to repetitively assume an expanded orientation and a contracted orientation. As such, structural and operative features of the positioning structure serve to repetitively and temporarily exert a “lifting” or “shaping” force on the exterior of the myocardium, specifically in the area of the ventricular wall supporting the tethered papillary muscle. The delivery of such a temporary and repetitive lifting or shaping force, in synchronization with the heartbeat or cardiac cycle, enable one of the mitral leaflets, typically a tethered posterior leaflet, to meet its anterior counterpart and coapt to a sufficient degree to eliminate or restrict mitral regurgitation. For purposes of clarity, the terms “lifting force” or “shaping force” or their equivalents are compatible in that the force exerted on the heart will temporarily and repetitively at least partially change the “shape” of the heart to the extent of “lifting” the left ventricular wall in a manner which facilitates a positioning of at least one of the mitral leaflets into a coapting relation with the other mitral leaflet.
Accordingly, the positioning structure is structured and operative to assume the expanded orientation and the contracted orientation on a repetitive basis in synchronization with the heartbeat. During the expanded orientation, the position the affected mitral leaflet is forced into a closed position during systoly and prevents or significantly restricts mitral regurgitation. Further, the positioning structure may be in the form of a flexible and/or expandable material bladder or “balloon”, which is capable of being inflated and deflated to assume the expanded and contracted orientations respectively.
A retaining assembly is positioned and structured to operatively dispose the positioning structure in moveably supporting relation to an exterior wall portion of the heart. As set forth above and in more specific terms, the retaining assembly and the positioning structure are cooperatively disposed, dimensioned and structured to operatively dispose the positioning structure in supporting and force exerting position relative to the ventricular wall portion with supports the tethered papillary muscle. Upon assumption of the positioning structure in the expanded orientation, the exertion of the lifting and shaping force is sufficient in degree and direction to enable the tethered posterior leaflet, or other affected leaflet, to meet its counterpart leaflet of the mitral valve and assume a sealing relation therewith.
Accordingly, at least one embodiment of the retaining assembly includes at least one substantially semi-rigid guide wire or like structure, having sufficient flexibility to be guided or maneuvered into a position about the ventricular wall or the large vessels of the cardiac outflow tracks, through the transfer sinus (sinus Theild). However, in at least one additional preferred embodiment the retaining assembly may include a retaining structure in the form of a net-like sack, sock or bag structure and/or configuration. Further, the net, sack, etc., is preferably formed from an open mesh material comprising a plurality of strands connected in at least partially spaced relation to one another. As such, the open mesh material of the retaining structure is dimensioned so as to at least partially overlie, enclose and/or surround the biventricular wall of the myocardium. In such a preferred position or orientation, the open mesh retaining structure will serve to dispose the expandable and contractible positioning structure in an appropriate position relative to the aforementioned ventricular wall associated with the tethered papillary muscle. In such position and as set forth above, the positioning structure will exert sufficient force, when expanded, to effectively “lift” the affected mitral leaflet into closing relation to the counterpart leaflet of the mitral valve.
When the positioning structure is in the form of the aforementioned inflatable structure such as, but not limited to, a bladder or balloon, a pump assembly is operatively associated therewith. More specifically the pump assembly and/or the main body of the pump is dimensioned and configured to be surgically inserted and maintained within the chest cavity in fluid communication with the inflatable positioning structure. Moreover, the pump assembly is structured, in cooperation with other operative components of the system of the present invention, to cause and regulate the inflation and deflation of the inflatable retaining structure in a manner which corresponds to and/or is synchronized with the intended heartbeat or cardiac cycle.
In yet another embodiment, at least a portion of the positioning structure comprises or is at least partially defined by the strands of the open mesh retaining structure. In such an embodiment, at least some of the strands are inflatable thereby enabling the transverse dimension or diameter of certain ones of the plurality of strands to expand and contract in accordance with their being inflated and deflated. In this embodiment, the pump is disposed in fluid communication with the plurality of inflatable/deflatable strands of the open mesh material, which may be used in combination with the inflatable and deflatable or expandable/contractible positioning structure. In contrast, the open mesh material comprising a plurality of inflatable strands may be used independent of any type of expandable or contractible positioning member. Therefore, the retaining structure may define an expandable or contractible positioning member to the extent of causing a “shape variance” of the myocardium. As indicated such a shape variance is applied to the extent of providing a lifting and/or positioning force on the ventricular wall associated with the tethered papillary muscle in order to lift or reposition an affected leaflet of the mitral valve into a closed orientation with its counterpart leaflet.
As emphasized, the heart shape varying force exerted on the heart wall by the expandable/contactable positioning structure, in its different forms described herein, should be synchronized with the heartbeat or cardiac cycle. Accordingly, the aforementioned pump assembly is operable in combination with an activating assembly connected to at least the retaining structure in an operative relation to the heart. The activating assembly is structured to detect electrical activity of the heart and as such may comprise a plurality of electrodes connected to the open mesh material of the retaining structure or other portions of a different embodiment of the retaining structure in a manner which detects such electrical activity.
In addition, the plurality of electrodes are operatively disposed in a predetermined array relative to the heart so as to facilitate the activating assembly having both “sensing” capabilities and “pacing” capabilities. As such, the sensing capabilities are operative to synchronize the expansion and contraction of the positioning structure so as to coincide with the cardiac cycle, as indicated above. Moreover, the pacing capabilities are operative to stimulate the heart into a biventricular resynchronization pacing. As used herein, the term “biventricular synchronization” is meant to include the stimulating or “pacing” of the heart in a manner that left and right ventricles expand and contract in a manner which facilitates normal or acceptable blood flow through the heart in accordance with a normal or acceptable cardiac cycle.
In order to accomplish the aforementmentioned sensing and pacing capabilities the activating assembly further comprises and/or is associated with a processor, electrically connected to the plurality of electrodes and to the operative circuitry associated with a processor. Therefore the combined circuitry of the processor, as well as the other operative components of the activating assembly, are operatively determinative of the sensing capabilities and facilitate the synchronized expansion and contraction of the positioning structure and/or the expansion and contraction of the inflatable strands of the retaining structure, dependent on the embodiment utilized.
Therefore, the system and the operative components associated therewith as well as the method of application for eliminating or restricting the occurrence of mitral regurgitation include the exertion of a force on the exterior of the heart wall thereby temporarily and repetitively providing “shape variance” of the heart. The variance in the shape of the heart will be caused by an effective “lifting” or positioning action exerted by an expansion of the positioning structure such that an affected leaflet such as, but not limited to, the posterior mitral valve leaflet, is lifted or positioned into a substantially sealing and/or closing engagement with its counterpart leaflet.
These and other objects, features and advantages of the present invention will become clearer when the drawings as well as the detailed description are taken into consideration.
For a fuller understanding of the nature of the present invention, reference should be had to the following detailed description taken in connection with the accompanying drawings in which:
Like reference numerals refer to like parts throughout the several views of the drawings.
As represented in the accompanied drawings, the present invention is directed to a system for treating heart valve malfunction specifically including mitral regurgitation, wherein the various operative structural components are represented throughout
In more specific terms, the system of the present invention is directed to an intra-pericardial, surgically introduced positioning structure 10 located between the inner surface of the pericardium 102 and the outer surface of the heart wall as explained in greater detail hereinafter. As such, the positioning structure 10 is operative to assume an expanded orientation and a contracted orientation. Therefore, the positioning member, in at least one preferred embodiment, may be in the form of an inflatable structure as at 10′ represented in
Moreover, the inflatable structure 10′ may be in the form of a flexible, inflatable material such as, but not limited to, a bladder or balloon structure. Moreover, the inflation and deflation of the positioning structure 10′ serves dispose it in the aforementioned aforementioned expanded and contracted orientations respectively. In cooperation therewith, a pump assembly generally indicated as 12 may disposed in fluid communication, as at 14, with the inflatable positioning member 10′ so as to cause its inflation/deflation and/or a disposition into the expanded and/or contracted orientation.
Due to its intended positioning between the inner surface of the pericardium 102 and the outer surface of the myocardium or heart wall in a preferred location, the exterior surface portions of positioning member 10 may be structured to facilitate engagement with the respective surfaces. As schematically represented in
More specifically, in the embodiment of
With additional reference to the prior art schematic representation of
As emphasized hereinafter repetitive lifting or exertion of force on the proper portion of the ventricular wall will be synchronized with the beating of the heart or cardiac cycle. Therefore, the affected mitral valve leaflet will be brought into closing relation with its counterpart leaflet on a regular and consistent basis in order to properly perform both systoly and dystoly of the heart during the cardiac cycle. Further, the lifting force is schematically represented in at least some of the accompanying Figures as directional arrows 120. As also emphasized, the lifting force 120 causes the temporary change in the shape of the heart 100 resulting in the lifting and positioning of the ventricular wall and leaflet of the mitral valve upon the intended expansion or inflation of the positioning member 10 or 10′.
The retaining assembly 20, as represented in
With primary reference to
Further, the inflatable strands 26 will be connected directly to the pump assembly 12 as at 14, and may be used in combination with an expandable and contactable positioning assembly 10 or 10′ which itself may or may not be inflatable. In contrast, the structuring of the retaining structure 24 to have at least some of the strands 26 being inflatable may be used independently of the positioning structure 10 or 10′. Moreover, the inflation and deflation of the plurality of strands 26 effectively defines the positioning structure at least to the extent of exerting sufficient forces 120 on the exterior of the heart wall to accomplish the preferred lifting or positioning of the ventricular wall and repositioning of the prolapsing leaflet of the mitral valve.
With primary reference to
Therefore, the sensing capabilities associated with the activating assembly 40 are operative to synchronize the expansion and contraction of the positioning assembly 10, 10′ with the heartbeat or cardiac cycle of the heart 100. As such, the expansion and/or inflation of the positioning structure 10, 10′ and/or the inflatable strands 26 of the retaining structure 24 will exert an appropriate lifting or positioning of the ventricular wall of the heart in accordance with the ventricular ejection phase or systoly of the heart causing the closure of the mitral valve leaflets, thereby restricting or preventing mitral regurgitation. In turn, the aforementioned pacing capabilities of the activating assembly 40 are operative to stimulate the heart into a biventricular resynchronization in order to perform normal or adequate systoly/diastoly functioning of the heart in a prescribed manner. As further indicated, the processor 44 and/or circuitry 46 may be electrically connected to the plurality of electrodes 42, as at 47 either through a hardwire connection passing through the thoracic chamber 104 or otherwise be disposed on the interior thereof. Such an electrical connection may occur by a hardwire connection 47 or other wireless connection as appropriate.
Since many modifications, variations and changes in detail can be made to the described preferred embodiment of the invention, it is intended that all matters in the foregoing description and shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense. Thus, the scope of the invention should be determined by the appended claims and their legal equivalents.
Now that the invention has been described,
Number | Name | Date | Kind |
---|---|---|---|
3587567 | Schiff | Jun 1971 | A |
4536893 | Parravicini | Aug 1985 | A |
4690134 | Snyders | Sep 1987 | A |
5201742 | Hasson | Apr 1993 | A |
5591170 | Spievack et al. | Jan 1997 | A |
5702421 | Schneidt | Dec 1997 | A |
6063070 | Eder | May 2000 | A |
6206907 | Marino et al. | Mar 2001 | B1 |
6328757 | Matheny | Dec 2001 | B1 |
6425911 | Akerfeldt et al. | Jul 2002 | B1 |
6508828 | Akerfeldt et al. | Jan 2003 | B1 |
6537290 | Adams et al. | Mar 2003 | B2 |
6596012 | Akerfeldt et al. | Jul 2003 | B2 |
6616596 | Milbocker | Sep 2003 | B1 |
6641592 | Sauer | Nov 2003 | B1 |
6682489 | Tenerz et al. | Jan 2004 | B2 |
6712837 | Åkerfeldt et al. | Mar 2004 | B2 |
6902522 | Walsh | Jun 2005 | B1 |
6929655 | Egnelöv et al. | Aug 2005 | B2 |
6960220 | Marino et al. | Nov 2005 | B2 |
7044916 | Tenerz et al. | May 2006 | B2 |
7445626 | Songer | Nov 2008 | B2 |
8092363 | Leinsing | Jan 2012 | B2 |
8133168 | Monnet | Mar 2012 | B2 |
8147542 | Maisano et al. | Apr 2012 | B2 |
8408214 | Spenser | Apr 2013 | B2 |
8506624 | Vidlund | Aug 2013 | B2 |
8758393 | Zentgraf | Jun 2014 | B2 |
8790394 | Miller | Jul 2014 | B2 |
20020100485 | Stevens et al. | Aug 2002 | A1 |
20020161378 | Downing | Oct 2002 | A1 |
20030120337 | Van Tassel et al. | Jun 2003 | A1 |
20040087831 | Michels et al. | May 2004 | A1 |
20040102804 | Chin | May 2004 | A1 |
20040106945 | Thramann et al. | Jun 2004 | A1 |
20040116897 | Aboul-Hosn | Jun 2004 | A1 |
20040138526 | Guenst | Jul 2004 | A1 |
20050137700 | Spence | Jun 2005 | A1 |
20050149108 | Cox | Jul 2005 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060135962 | Kick et al. | Jun 2006 | A1 |
20060247672 | Vidlund et al. | Nov 2006 | A1 |
20070055206 | To | Mar 2007 | A1 |
20070135826 | Zaver et al. | Jun 2007 | A1 |
20070162066 | Lyon | Jul 2007 | A1 |
20070239108 | Albrecht et al. | Oct 2007 | A1 |
20070265643 | Beane et al. | Nov 2007 | A1 |
20080033241 | Peh et al. | Feb 2008 | A1 |
20080114342 | Whayne et al. | May 2008 | A1 |
20080275295 | Gertner | Nov 2008 | A1 |
20090005800 | Franer | Jan 2009 | A1 |
20090105751 | Zentgraf | Apr 2009 | A1 |
20090192598 | Lattouf | Jul 2009 | A1 |
20100042147 | Janovsky | Feb 2010 | A1 |
20100161042 | Maisano et al. | Jun 2010 | A1 |
20100161043 | Maisano | Jun 2010 | A1 |
20100179574 | Longoria et al. | Jul 2010 | A1 |
20100228077 | Lenker et al. | Sep 2010 | A1 |
20100274091 | Rothstein et al. | Oct 2010 | A1 |
20110029071 | Zlotnick et al. | Feb 2011 | A1 |
20110060182 | Kassab et al. | Mar 2011 | A1 |
20110166413 | Alferness | Jul 2011 | A1 |
20110190811 | Shanley | Aug 2011 | A1 |
20120143209 | Brecheen et al. | Jun 2012 | A1 |
20120272452 | Schultz | Nov 2012 | A1 |
20120272495 | Hildebrandt et al. | Nov 2012 | A1 |
20120272497 | Smith | Nov 2012 | A1 |
20120272499 | Schley et al. | Nov 2012 | A1 |
20120272523 | Calla et al. | Nov 2012 | A1 |
20120272555 | Heath | Nov 2012 | A1 |
20120272556 | Brown | Nov 2012 | A1 |
20120272595 | Gallant | Nov 2012 | A1 |
20120272603 | Carbines | Nov 2012 | A1 |
20120272611 | Tsukimoto et al. | Nov 2012 | A1 |
20120272624 | Argeriou et al. | Nov 2012 | A1 |
20120272632 | Lans | Nov 2012 | A1 |
20120272637 | Holland et al. | Nov 2012 | A1 |
20120272652 | Nicholls et al. | Nov 2012 | A1 |
20120272653 | Merrill et al. | Nov 2012 | A1 |
20120272660 | Garrett | Nov 2012 | A1 |
20120272661 | Milburn | Nov 2012 | A1 |
20120272662 | Milburn | Nov 2012 | A1 |
20120272667 | Ferraro et al. | Nov 2012 | A1 |
20120272670 | Choi et al. | Nov 2012 | A1 |
20120272705 | Hirane | Nov 2012 | A1 |
20120272738 | Klessel et al. | Nov 2012 | A1 |
20120272741 | Xiao et al. | Nov 2012 | A1 |
20120272768 | Schmidt et al. | Nov 2012 | A1 |
20120272780 | Schimings et al. | Nov 2012 | A1 |
20120272815 | Lingel et al. | Nov 2012 | A1 |
20120272817 | Lindh, Sr. et al. | Nov 2012 | A1 |
20120272841 | Heymanns et al. | Nov 2012 | A1 |
20120272843 | Graff | Nov 2012 | A1 |
20120272845 | Loiret-Bernal et al. | Nov 2012 | A1 |
20120272846 | Fleischer et al. | Nov 2012 | A1 |
20120272876 | Bergeron et al. | Nov 2012 | A1 |
20120272893 | Lauerhaas et al. | Nov 2012 | A1 |
20120272968 | Kirschner | Nov 2012 | A1 |
20120272996 | Jimenez et al. | Nov 2012 | A1 |
20120273014 | Tadayon | Nov 2012 | A1 |
20120273064 | Ismert et al. | Nov 2012 | A1 |
20120273078 | Hawwa et al. | Nov 2012 | A1 |
20120273079 | Guclucan | Nov 2012 | A1 |
20120273141 | Miller et al. | Nov 2012 | A1 |
20120273142 | Miller et al. | Nov 2012 | A1 |
20120273143 | Fillmore et al. | Nov 2012 | A1 |
20120273161 | Raver | Nov 2012 | A1 |
20120273174 | Barnes | Nov 2012 | A1 |
20120273178 | Wanni et al. | Nov 2012 | A1 |
20120273209 | Austin et al. | Nov 2012 | A1 |
20120273210 | Arizmendi, Jr. et al. | Nov 2012 | A1 |
20120273214 | Donald et al. | Nov 2012 | A1 |
20120273219 | Hoffman et al. | Nov 2012 | A1 |
20120273220 | Ezekiel et al. | Nov 2012 | A1 |
20120273228 | Allouche | Nov 2012 | A1 |
20120273230 | Patterson et al. | Nov 2012 | A1 |
20120273231 | Whiddon | Nov 2012 | A1 |
20120273232 | O'Blenes | Nov 2012 | A1 |
20120273328 | Sejourne | Nov 2012 | A1 |
20120273358 | Lamoy et al. | Nov 2012 | A1 |
20120273389 | Aziz et al. | Nov 2012 | A1 |
20120273399 | Daboub et al. | Nov 2012 | A1 |
20120273438 | Nordin et al. | Nov 2012 | A1 |
20120273439 | Beavers et al. | Nov 2012 | A1 |
20120273458 | Bret et al. | Nov 2012 | A1 |
20120273467 | Baxter et al. | Nov 2012 | A1 |
20120273470 | Zediker et al. | Nov 2012 | A1 |
20120273518 | Greer, Jr. | Nov 2012 | A1 |
20120273555 | Flak et al. | Nov 2012 | A1 |
20120273580 | Warren et al. | Nov 2012 | A1 |
20120273641 | Gorman et al. | Nov 2012 | A1 |
20120273647 | Moruzzi | Nov 2012 | A1 |
20120273680 | Furry | Nov 2012 | A1 |
20120273843 | Kim | Nov 2012 | A1 |
20120273860 | Chen et al. | Nov 2012 | A1 |
20120273880 | Teng et al. | Nov 2012 | A1 |
20120273902 | Lin et al. | Nov 2012 | A1 |
20120273955 | Or-Bach et al. | Nov 2012 | A1 |
20120273987 | Belcher et al. | Nov 2012 | A1 |
20120273989 | Graf | Nov 2012 | A1 |
20120273993 | Shoeeyov et al. | Nov 2012 | A1 |
20120274001 | Prabhu | Nov 2012 | A1 |
20120274020 | Daboub | Nov 2012 | A1 |
20120274061 | Wilkinson | Nov 2012 | A1 |
20120274065 | Knapp | Nov 2012 | A1 |
20120274068 | Hanback | Nov 2012 | A1 |
20120274076 | Kelaiditis et al. | Nov 2012 | A1 |
20120274145 | Taddeo | Nov 2012 | A1 |
20120274198 | Jenek | Nov 2012 | A1 |
20120274202 | Komatsu | Nov 2012 | A1 |
20120274212 | Yu et al. | Nov 2012 | A1 |
20120274256 | O'Rourke | Nov 2012 | A1 |
20120274266 | Yip | Nov 2012 | A1 |
20120274279 | Banos et al. | Nov 2012 | A1 |
20120274280 | Yip et al. | Nov 2012 | A1 |
20120274281 | Kim | Nov 2012 | A1 |
20120274288 | Wegener | Nov 2012 | A1 |
20120274332 | Sinha et al. | Nov 2012 | A1 |
20120274391 | Kim | Nov 2012 | A1 |
20120274395 | Deam | Nov 2012 | A1 |
20120274440 | Meadows et al. | Nov 2012 | A1 |
20120274470 | Sandvick | Nov 2012 | A1 |
20120274477 | Prammer | Nov 2012 | A1 |
20120274769 | Lee | Nov 2012 | A1 |
20120274770 | Lee | Nov 2012 | A1 |
20120274772 | Fosburgh et al. | Nov 2012 | A1 |
20120274870 | Liu | Nov 2012 | A1 |
20120274937 | Hays et al. | Nov 2012 | A1 |
20120274962 | Thomas et al. | Nov 2012 | A1 |
20120275056 | McGuire, Jr. | Nov 2012 | A1 |
20120275057 | McGuire, Jr. | Nov 2012 | A1 |
20120275085 | Wilson et al. | Nov 2012 | A1 |
20120275128 | Takada et al. | Nov 2012 | A1 |
20120275140 | Feinbloom et al. | Nov 2012 | A1 |
20120275236 | Hess et al. | Nov 2012 | A1 |
20120275244 | Do | Nov 2012 | A1 |
20120275247 | Hwang et al. | Nov 2012 | A1 |
20120275248 | Won | Nov 2012 | A1 |
20120275249 | Yang et al. | Nov 2012 | A1 |
20120275298 | Bryant et al. | Nov 2012 | A1 |
20120275299 | Taylor et al. | Nov 2012 | A1 |
20120275338 | Filsfils et al. | Nov 2012 | A1 |
20120275356 | Aharony et al. | Nov 2012 | A1 |
20120275670 | Joglekar | Nov 2012 | A1 |
20120275754 | Krampotich et al. | Nov 2012 | A1 |
20120275841 | Jimenez et al. | Nov 2012 | A1 |
20120275843 | Jimenez et al. | Nov 2012 | A1 |
20120275845 | Etling | Nov 2012 | A1 |
20120275860 | Exline | Nov 2012 | A1 |
20120275861 | Myslowski et al. | Nov 2012 | A1 |
20120275862 | Vitale | Nov 2012 | A1 |
20120275881 | Mueller | Nov 2012 | A1 |
20120275913 | Robertson, Jr. et al. | Nov 2012 | A1 |
20120275924 | Perkinson | Nov 2012 | A1 |
20120275927 | Rhim | Nov 2012 | A1 |
20120275970 | Nash et al. | Nov 2012 | A1 |
20120275999 | Bell et al. | Nov 2012 | A1 |
20120276005 | Yang et al. | Nov 2012 | A1 |
20120276008 | Walkenhorst et al. | Nov 2012 | A1 |
20120276009 | Pfeifer et al. | Nov 2012 | A1 |
20120276011 | Kupussamy et al. | Nov 2012 | A1 |
20120276021 | Kumar et al. | Nov 2012 | A1 |
20120276025 | Florence et al. | Nov 2012 | A1 |
20120276041 | Salamone et al. | Nov 2012 | A1 |
20120276053 | Kim | Nov 2012 | A1 |
20120276061 | Grazia et al. | Nov 2012 | A1 |
20120276062 | Kellar et al. | Nov 2012 | A1 |
20120276064 | Blau et al. | Nov 2012 | A1 |
20120276067 | Westenfelder | Nov 2012 | A1 |
20120276068 | Sabaawy | Nov 2012 | A1 |
20120276069 | Karperien et al. | Nov 2012 | A1 |
20120276071 | Fraser, Jr. | Nov 2012 | A1 |
20120276073 | Schachner et al. | Nov 2012 | A1 |
20120276074 | Scharenberg et al. | Nov 2012 | A1 |
20120276080 | Kinoshita et al. | Nov 2012 | A1 |
20120276084 | Schaumberg et al. | Nov 2012 | A1 |
20120276087 | Schafer et al. | Nov 2012 | A1 |
20120276088 | El-Deiry et al. | Nov 2012 | A1 |
20120276089 | Lee et al. | Nov 2012 | A1 |
20120276101 | Kwak et al. | Nov 2012 | A1 |
20120276103 | Karperien et al. | Nov 2012 | A1 |
20120276104 | Woisetschlager | Nov 2012 | A1 |
20120276110 | Simard | Nov 2012 | A1 |
20120276111 | Hafezi-Moghadam | Nov 2012 | A1 |
20120276126 | Varadhachary et al. | Nov 2012 | A1 |
20120276130 | Margarit Y Ros et al. | Nov 2012 | A1 |
20120276139 | Moormann et al. | Nov 2012 | A1 |
20120276143 | O'Mahony et al. | Nov 2012 | A1 |
20120276144 | Kernodle et al. | Nov 2012 | A1 |
20120276149 | Littman et al. | Nov 2012 | A1 |
20120276150 | Lauritzen et al. | Nov 2012 | A1 |
20120276151 | Lewis et al. | Nov 2012 | A1 |
20120276152 | Hossainy et al. | Nov 2012 | A1 |
20120276161 | Gravagna et al. | Nov 2012 | A1 |
20120276164 | Tuominen et al. | Nov 2012 | A1 |
20120276169 | Kang et al. | Nov 2012 | A1 |
20120276173 | Marcum et al. | Nov 2012 | A1 |
20120276182 | Baker, Jr. et al. | Nov 2012 | A1 |
20120276185 | Hossainy et al. | Nov 2012 | A1 |
20120276188 | Barrows | Nov 2012 | A1 |
20120276189 | Johnson | Nov 2012 | A1 |
20120276193 | Graversen et al. | Nov 2012 | A1 |
20120276201 | Trachtman | Nov 2012 | A1 |
20120276202 | Selim et al. | Nov 2012 | A1 |
20120276203 | Selim et al. | Nov 2012 | A1 |
20120276204 | Remington et al. | Nov 2012 | A1 |
20120276213 | Chen | Nov 2012 | A1 |
20120276218 | Jung et al. | Nov 2012 | A1 |
20120276232 | Marczyk et al. | Nov 2012 | A1 |
20120276237 | Heymanns et al. | Nov 2012 | A1 |
20120276278 | Qiu et al. | Nov 2012 | A1 |
20120276286 | Vijayakumar | Nov 2012 | A1 |
20120276296 | Fieberg et al. | Nov 2012 | A1 |
20120276297 | Cypcar et al. | Nov 2012 | A1 |
20120276304 | Derrien | Nov 2012 | A1 |
20120276330 | Durney et al. | Nov 2012 | A1 |
20120276365 | Petuskey et al. | Nov 2012 | A1 |
20120276375 | Colgan et al. | Nov 2012 | A1 |
20120276381 | Cypcar | Nov 2012 | A1 |
20120276427 | Kim | Nov 2012 | A1 |
20120276463 | Grannell et al. | Nov 2012 | A1 |
20120276465 | Paganelli | Nov 2012 | A1 |
20120276469 | Shizuku | Nov 2012 | A1 |
20120276509 | Iannotti et al. | Nov 2012 | A1 |
20120276518 | Gillis | Nov 2012 | A1 |
20120276522 | Huang et al. | Nov 2012 | A1 |
20120276528 | Cargill et al. | Nov 2012 | A1 |
20120276529 | Galisson et al. | Nov 2012 | A1 |
20120276537 | Kühn et al. | Nov 2012 | A1 |
20120276552 | Lu | Nov 2012 | A1 |
20120276553 | Gronthos et al. | Nov 2012 | A1 |
20120276554 | Gutteridge et al. | Nov 2012 | A1 |
20120276555 | Kuhn et al. | Nov 2012 | A1 |
20120276558 | Soper et al. | Nov 2012 | A1 |
20120276572 | Shekdar et al. | Nov 2012 | A1 |
20120276581 | Arav et al. | Nov 2012 | A1 |
20120276588 | Hallen-Adams et al. | Nov 2012 | A1 |
20120276591 | Kneissel et al. | Nov 2012 | A1 |
20120276618 | Dayton et al. | Nov 2012 | A1 |
20120276626 | Shogbon et al. | Nov 2012 | A1 |
20120276627 | Kelnar et al. | Nov 2012 | A1 |
20120276628 | Khen et al. | Nov 2012 | A1 |
20120276632 | Strunk et al. | Nov 2012 | A1 |
20120276679 | Wu | Nov 2012 | A1 |
20120276694 | Koezuka et al. | Nov 2012 | A1 |
20120276754 | Cordingley et al. | Nov 2012 | A1 |
20120276887 | Romine et al. | Nov 2012 | A1 |
20120276928 | Shutter | Nov 2012 | A1 |
20120277006 | Kim | Nov 2012 | A1 |
20120277008 | Kitchen et al. | Nov 2012 | A1 |
20120277051 | Cooper et al. | Nov 2012 | A1 |
20120277073 | Bartsch | Nov 2012 | A1 |
20120277093 | Andrew et al. | Nov 2012 | A1 |
20120277110 | Andre et al. | Nov 2012 | A1 |
20120277111 | Crabtree et al. | Nov 2012 | A1 |
20120277112 | Linn et al. | Nov 2012 | A1 |
20120277118 | Bhatia et al. | Nov 2012 | A1 |
20120277120 | Serber et al. | Nov 2012 | A1 |
20120277144 | Duckers | Nov 2012 | A1 |
20120277152 | Ringeisen et al. | Nov 2012 | A1 |
20120277155 | VanAntwerp et al. | Nov 2012 | A1 |
20120277156 | Gross et al. | Nov 2012 | A1 |
20120277157 | Hillman | Nov 2012 | A1 |
20120277161 | Agrez et al. | Nov 2012 | A1 |
20120277162 | Krasnoperov et al. | Nov 2012 | A1 |
20120277173 | Eidenberger | Nov 2012 | A1 |
20120277179 | Bhargava | Nov 2012 | A1 |
20120277195 | Banov et al. | Nov 2012 | A1 |
20120277203 | Lasley et al. | Nov 2012 | A1 |
20120277204 | Taniguchi et al. | Nov 2012 | A1 |
20120277205 | Badorc et al. | Nov 2012 | A1 |
20120277210 | Catron et al. | Nov 2012 | A1 |
20120277215 | Ksander et al. | Nov 2012 | A1 |
20120277228 | Sutton et al. | Nov 2012 | A1 |
20120277229 | Bearss et al. | Nov 2012 | A1 |
20120277251 | Palladino et al. | Nov 2012 | A1 |
20120277265 | Deraeve et al. | Nov 2012 | A1 |
20120277269 | Reilly | Nov 2012 | A1 |
20120277271 | Nadeson et al. | Nov 2012 | A1 |
20120277277 | Wallace et al. | Nov 2012 | A1 |
20120277279 | Barnett et al. | Nov 2012 | A1 |
20120277282 | Gotthardt et al. | Nov 2012 | A1 |
20120277288 | Drumm et al. | Nov 2012 | A1 |
20120277307 | Waddell | Nov 2012 | A1 |
20120277309 | Gass et al. | Nov 2012 | A1 |
20120277312 | Mink et al. | Nov 2012 | A1 |
20120277316 | Tillman et al. | Nov 2012 | A1 |
20120277319 | Steigerwald et al. | Nov 2012 | A1 |
20120277324 | Burk et al. | Nov 2012 | A1 |
20120277364 | Lolli et al. | Nov 2012 | A1 |
20120277376 | Baker, Jr. et al. | Nov 2012 | A1 |
20120277382 | Booth et al. | Nov 2012 | A1 |
20120277412 | Furusako et al. | Nov 2012 | A1 |
20120277430 | Taniguchi et al. | Nov 2012 | A1 |
20120277431 | Taniguchi et al. | Nov 2012 | A1 |
20120277451 | Ochiai | Nov 2012 | A1 |
20120277453 | Franklin et al. | Nov 2012 | A1 |
20120277517 | Ivkov et al. | Nov 2012 | A1 |
20120277521 | Chamberlin | Nov 2012 | A1 |
20120277522 | Shalon et al. | Nov 2012 | A1 |
20120277523 | Shalon et al. | Nov 2012 | A1 |
20120277537 | Kucklick et al. | Nov 2012 | A1 |
20120277544 | Fernandes et al. | Nov 2012 | A1 |
20120277546 | Soykan et al. | Nov 2012 | A1 |
20120277567 | Harlev et al. | Nov 2012 | A1 |
20120277572 | Hubbard | Nov 2012 | A1 |
20120277574 | Panescu | Nov 2012 | A1 |
20120277576 | Lui | Nov 2012 | A1 |
20120277578 | Gunday et al. | Nov 2012 | A1 |
20120277582 | Mali | Nov 2012 | A1 |
20120277584 | Tanaka et al. | Nov 2012 | A1 |
20120277592 | Zelenka et al. | Nov 2012 | A1 |
20120277599 | Greenhut | Nov 2012 | A1 |
20120277600 | Greenhut | Nov 2012 | A1 |
20120277618 | Giftakis et al. | Nov 2012 | A1 |
20120277621 | Gerber et al. | Nov 2012 | A1 |
20120277624 | Cucin | Nov 2012 | A1 |
20120277626 | Burbank et al. | Nov 2012 | A1 |
20120277638 | Skelton et al. | Nov 2012 | A1 |
20120277639 | Pollock et al. | Nov 2012 | A1 |
20120277642 | Smith et al. | Nov 2012 | A1 |
20120277668 | Chawla | Nov 2012 | A1 |
20120277671 | Fuentes | Nov 2012 | A1 |
20120277672 | Pepper et al. | Nov 2012 | A1 |
20120277674 | Clark, III et al. | Nov 2012 | A1 |
20120277693 | Bailey | Nov 2012 | A1 |
20120277716 | Ali et al. | Nov 2012 | A1 |
20120277718 | Campbell et al. | Nov 2012 | A1 |
20120277720 | Humes et al. | Nov 2012 | A1 |
20120277725 | Kassab et al. | Nov 2012 | A1 |
20120277729 | Melsheimer | Nov 2012 | A1 |
20120277730 | Salahieh et al. | Nov 2012 | A1 |
20120277736 | Francischelli | Nov 2012 | A1 |
20120277740 | Warnking et al. | Nov 2012 | A1 |
20120277741 | Davalos et al. | Nov 2012 | A1 |
20120277743 | Vallittu | Nov 2012 | A1 |
20120277746 | Morgan et al. | Nov 2012 | A1 |
20120277749 | Mootien et al. | Nov 2012 | A1 |
20120277752 | Wasielewski | Nov 2012 | A1 |
20120277753 | Linderman et al. | Nov 2012 | A1 |
20120277756 | Ray et al. | Nov 2012 | A1 |
20120277766 | Ferree | Nov 2012 | A1 |
20120277770 | Fenton et al. | Nov 2012 | A1 |
20120277771 | Vaz et al. | Nov 2012 | A1 |
20120277772 | Aben et al. | Nov 2012 | A1 |
20120277773 | Sargeant et al. | Nov 2012 | A1 |
20120277774 | Guo | Nov 2012 | A1 |
20120277776 | Kraemer et al. | Nov 2012 | A1 |
20120277781 | Gertner | Nov 2012 | A1 |
20120277784 | Berez et al. | Nov 2012 | A1 |
20120277785 | Aggerholm et al. | Nov 2012 | A1 |
20120277786 | Mohl | Nov 2012 | A1 |
20120277791 | Abo-Auda et al. | Nov 2012 | A1 |
20120277792 | Teeslink et al. | Nov 2012 | A1 |
20120277793 | Marczyk et al. | Nov 2012 | A1 |
20120277798 | Benson et al. | Nov 2012 | A1 |
20120277800 | Jackson | Nov 2012 | A1 |
20120277807 | Myung et al. | Nov 2012 | A1 |
20120277811 | Lauchner et al. | Nov 2012 | A1 |
20120277812 | Kraus | Nov 2012 | A1 |
20120277814 | Schuler | Nov 2012 | A1 |
20120277820 | Wu et al. | Nov 2012 | A1 |
20120277823 | Gerber et al. | Nov 2012 | A1 |
20120277825 | Mawson et al. | Nov 2012 | A1 |
20120277833 | Gerber et al. | Nov 2012 | A1 |
20120277835 | Della Santina et al. | Nov 2012 | A1 |
20120277837 | Schuler | Nov 2012 | A1 |
20120277843 | Weber et al. | Nov 2012 | A1 |
20120277845 | Bowe | Nov 2012 | A1 |
20120277846 | Schreck et al. | Nov 2012 | A1 |
20120277852 | Shukla et al. | Nov 2012 | A1 |
20120277853 | Rothstein | Nov 2012 | A1 |
20120277854 | Ryan | Nov 2012 | A1 |
20120277855 | Lashinski et al. | Nov 2012 | A1 |
20120277856 | Spenser et al. | Nov 2012 | A1 |
20120277862 | Tornier et al. | Nov 2012 | A1 |
20120277864 | Brodke et al. | Nov 2012 | A1 |
20120277865 | Trieu et al. | Nov 2012 | A1 |
20120277867 | Kana et al. | Nov 2012 | A1 |
20120277872 | Kana et al. | Nov 2012 | A1 |
20120277873 | Kana et al. | Nov 2012 | A1 |
20120277879 | Ripamonti | Nov 2012 | A1 |
20120277880 | Winslow et al. | Nov 2012 | A1 |
20120277882 | Huang et al. | Nov 2012 | A1 |
20120277896 | Uekita et al. | Nov 2012 | A1 |
20120277903 | Schaefer | Nov 2012 | A1 |
20120277939 | Kumar | Nov 2012 | A1 |
20120277940 | Kumar et al. | Nov 2012 | A1 |
20120277949 | Ghimire et al. | Nov 2012 | A1 |
20120277979 | Kato et al. | Nov 2012 | A1 |
20120277998 | Bevilacqua et al. | Nov 2012 | A1 |
20120277999 | Somogyi et al. | Nov 2012 | A1 |
20120278032 | Chen | Nov 2012 | A1 |
20120278098 | Vovan et al. | Nov 2012 | A1 |
20120278099 | Kelly et al. | Nov 2012 | A1 |
20120278123 | Houle | Nov 2012 | A1 |
20120278144 | Popilock et al. | Nov 2012 | A1 |
20120278195 | Joseph | Nov 2012 | A1 |
20120278200 | van Coppenolle et al. | Nov 2012 | A1 |
20120278236 | Jain et al. | Nov 2012 | A1 |
20120278242 | Griffith | Nov 2012 | A1 |
20120278411 | Lavine | Nov 2012 | A1 |
20120278439 | Ahiska et al. | Nov 2012 | A1 |
20120278454 | Stewart et al. | Nov 2012 | A1 |
20120278484 | Westphal | Nov 2012 | A1 |
20120278520 | Barrenscheen et al. | Nov 2012 | A1 |
20120278554 | Eilert | Nov 2012 | A1 |
20120278592 | Tran | Nov 2012 | A1 |
20120278597 | De Atley et al. | Nov 2012 | A1 |
20120278654 | Shen et al. | Nov 2012 | A1 |
20120278657 | Baker et al. | Nov 2012 | A1 |
20120278676 | Teraura | Nov 2012 | A1 |
20120278684 | Eldredge et al. | Nov 2012 | A1 |
20120278689 | Tamo et al. | Nov 2012 | A1 |
20120278760 | Cemy et al. | Nov 2012 | A1 |
20120278771 | Ren | Nov 2012 | A1 |
20120278799 | Starks et al. | Nov 2012 | A1 |
20120278865 | Sawdy | Nov 2012 | A1 |
20120278913 | Fraser | Nov 2012 | A1 |
20120278947 | Guo et al. | Nov 2012 | A1 |
20120278957 | Phan et al. | Nov 2012 | A1 |
20120283758 | Miller | Nov 2012 | A1 |
20130041395 | De Canniere | Feb 2013 | A1 |
20130066275 | De Canniere | Mar 2013 | A1 |
Number | Date | Country |
---|---|---|
0577400 | Oct 1999 | EP |
1147743 | Oct 2001 | EP |
1169968 | Jan 2002 | EP |
1222896 | Jul 2002 | EP |
1266626 | Dec 2002 | EP |
1269919 | Jan 2003 | EP |
1254634 | Jul 2003 | EP |
1244725 | Jul 2005 | EP |
1773239 | Mar 2010 | EP |
WO 2012 040865 | Apr 2012 | WO |
WO2012040865 | Apr 2012 | WO |
WO2012016398 | Sep 2012 | WO |
WO2013023016 | Feb 2013 | WO |
WO 2013036742 | Mar 2013 | WO |
WO2015081053 | Jun 2015 | WO |
Entry |
---|
Mike Blaber, Metals, Non-Metals, and Metalloids, http://www.mikeblaber.org/oldwine/chm 1045/notes/Periodic/Metals/Period06.htm, 1996, accessed May 14, 2015. |
Number | Date | Country | |
---|---|---|---|
20150148590 A1 | May 2015 | US |